Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Catheters

FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent

By

Medtronic (NYSE:MDT) announced today that it received FDA approval for its Onyx Frontier drug-eluting stent (DES). Onyx Frontier, the latest iteration of Medtronic’s Resolute DES family, was designed to leverage the same stent platform as Resolute with an enhanced delivery system for improving deliverability and increasing acute performance, … [Read more...] about FDA approves Medtronic’s Onyx Frontier drug-eluting coronary stent

Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes

By

Abbott (NYSE:ABT) announced today that its Xience Skypoint drug-eluting stent platform is now available globally. Xience Skypoint has received FDA approval, CE mark and PMDA approval in Japan for the broadest expansion with the availability of extended sizes of 4.5 mm and 5 mm offerings. Get the full story at our sister site, Drug Delivery … [Read more...] about Abbott announces availability of Xience Skypoint drug-eluting stent in extended sizes

ICU Medical beats The Street in Q1

By

ICU Medical (Nasdaq:ICUI) reported first-quarter results that came in ahead of the consensus earnings per share forecast. The San Clemente, California-based company posted losses of $38.1 million, or $1.61 per share, on sales of $543.1 million for the three months ended March 31, 2022, for a bottom-line slide into the red on sales growth of … [Read more...] about ICU Medical beats The Street in Q1

Avanos rises as Q1 earnings match Wall Street projections

By

Avanos Medical (NYSE:AVNS) shares ticked up today on first-quarter results that just about matched the consensus forecast. The Alpharetta, Georgia–based pain management and chronic care device company posted profits of $5.8 million, or 12¢ per share, on sales of $197.4 million for the three months ended March 31, 2022, for a bottom-line gain … [Read more...] about Avanos rises as Q1 earnings match Wall Street projections

Boston Scientific wins FDA clearance for Embold fibered detached coil

By

Boston Scientific (NYSE:BSX) this week announced it received FDA 510(k) clearance for the Embold fibered detachable coil for use in the peripheral vasculature. Marlborough, Massachusetts-based Boston Scientific designed Embold for use in a number of embolization procedures that block one or more blood vessels to obstruct or reduce blood flow. … [Read more...] about Boston Scientific wins FDA clearance for Embold fibered detached coil

Study demonstrates freedom from AFib symptoms with use of Abbott’s ablation catheter

By

Abbott (NYSE:ABT) announced today that a study showed its TactiCath ablation catheter often led to more than a year of freedom from AFib symptoms. The Persist-End study showed that 89% of patients treated for persistent AFib with the company’s TactiCath contact force ablation catheter, Sensor Enabled (TactiCath SE), remained symptom-free for up … [Read more...] about Study demonstrates freedom from AFib symptoms with use of Abbott’s ablation catheter

LeMaitre Vascular grows sales 10% in Q1 results

By

Lemaitre Vascular (NSDQ:LMAT) posted first-quarter results that beat the revenue consensus on Wall Street and missed earnings estimates. The Burlington, Massachusetts-based vascular device company reported profits of $6 million, or 27¢ per share on sales of $39.6 million for the three months ended March 31, for a bottom-line gain of 1.8% on … [Read more...] about LeMaitre Vascular grows sales 10% in Q1 results

CathVision completes patient enrollment in ECGenius EP recording system clinical trial

By

CathVision this week announced it completed patient enrollment in the CathVision ECGenius System clinical study. The company anticipates FDA 510(k) clearance for the ECGenius System within the next two weeks, a company representative said. The clinical evaluation study is being conducted at the University of Vermont Medical Center and will … [Read more...] about CathVision completes patient enrollment in ECGenius EP recording system clinical trial

Abbott announces U.S. launch of Amplatzer steerable delivery sheath for Amulet device

By

Abbott (NYSE:ABT) announced today that it made the Amplatzer steerable delivery sheath commercially available in the U.S. The Amplatzer steerable delivery sheath works with the Amplatzer Amulet left atrial appendage (LAA) occluder to treat people with AFib who are at risk of ischemic stroke According to a news release, the Amulet with … [Read more...] about Abbott announces U.S. launch of Amplatzer steerable delivery sheath for Amulet device